244 related articles for article (PubMed ID: 6457406)
1. [Effect of levamisole (Decaris) on various immunologic parameters in patients with systemic lupus erythematosus].
Gandzha IM; Sakharchuk VM; Lysenko GI
Ter Arkh; 1981; 53(7):121-4. PubMed ID: 6457406
[No Abstract] [Full Text] [Related]
2. The treatment of systemic lupus erythematosus (SLE) with the T-cell immunostimulant drug levamisole: A case report.
Gordon BL; Keenan JP
Ann Allergy; 1975 Dec; 35(6):343-55. PubMed ID: 1081857
[TBL] [Abstract][Full Text] [Related]
3. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
Pozsonyi T; Jakab L; Fehér J
Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis of T-immunodeficiencies in lupus erythematosus and patient treatment with levamisole].
Shaposhnikov OK; Gorbunov VF
Vestn Dermatol Venerol; 1979 Mar; (3):3-6. PubMed ID: 311566
[No Abstract] [Full Text] [Related]
5. Treatment of systemic lupus erythematosus with the T-cell immunopotentiator levamisole: a follow-up report of 16 patients under treatment for a minimum period of four months.
Gordon BL; Yanagihara R
Ann Allergy; 1977 Oct; 39(4):227-36. PubMed ID: 71868
[TBL] [Abstract][Full Text] [Related]
6. The in vitro effect of levamisole on histamine inhibited E-rosette forming T-lymphocyte subpopulation in patients affected by disseminated erythematosus lupus.
Pozsonyi T; Jakab L; Fehér J; Cseh K
Allergol Immunopathol (Madr); 1982; 10(6):435-9. PubMed ID: 6220589
[TBL] [Abstract][Full Text] [Related]
7. [Cytotoxicity of human lymphocytes induced by antibody: response in patients with systemic lupus erythematosus and effect of immunosuppressive treatment].
Manni JA; de Bracco MM; Patrucco A
Medicina (B Aires); 1974; 34(3):185-93. PubMed ID: 4547009
[No Abstract] [Full Text] [Related]
8. Phenotypic changes of lymphocytes in patients with systemic lupus erythematosus who are in longterm remission after B cell depletion therapy with rituximab.
Iwata S; Saito K; Tokunaga M; Yamaoka K; Nawata M; Yukawa S; Hanami K; Fukuyo S; Miyagawa I; Kubo S; Tanaka Y
J Rheumatol; 2011 Apr; 38(4):633-41. PubMed ID: 21159836
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of systemic lupus erythematosus.
Francis L; Perl A
Expert Opin Pharmacother; 2009 Jun; 10(9):1481-94. PubMed ID: 19505215
[TBL] [Abstract][Full Text] [Related]
10. [Effect of prednisolone and azathioprine on T- and B-lymphocyte number in peripheral blood of patients with glomerulonephritis and systemic lupus erythematosus].
Shilov EM; Tareeva IE; Gordovskaia NB
Ter Arkh; 1978; 50(6):60-7. PubMed ID: 307828
[No Abstract] [Full Text] [Related]
11. [Levamisole and its effect on the E-rosette restoration test in healthy subjects and in systemic lupus erythematosus (author's transl)].
Rovenský J; Pekárek J; Holt PJ; Mistina T; Zitnan D
Cas Lek Cesk; 1981 Jun; 120(25):761-3. PubMed ID: 7260993
[No Abstract] [Full Text] [Related]
12. Levamisole in systemic lupus erythematosus.
Ogawa K; Sano T; Hisano G; Tsubura E
Ann Allergy; 1979 Sep; 43(3):187-9. PubMed ID: 314248
[TBL] [Abstract][Full Text] [Related]
13. Levamisole in the treatment of systemic lupus erythematosus--preliminary results.
Feng PH; Oon CJ; Yo SL; Lau YK
Singapore Med J; 1978 Sep; 19(3):120-4. PubMed ID: 751195
[No Abstract] [Full Text] [Related]
14. B cell activation in patients with active procainamide induced lupus.
Forrester J; Golbus J; Brede D; Hudson J; Richardson B
J Rheumatol; 1988 Sep; 15(9):1384-8. PubMed ID: 3264337
[TBL] [Abstract][Full Text] [Related]
15. [Effect of prednisolone and heparin on circulating T- and B-lymphocytes in glomerulonephritis and systemic lupus erythematosus].
Tareeva IE; Shilov EM
Klin Med (Mosk); 1978 Jul; 56(7):79-84. PubMed ID: 355719
[No Abstract] [Full Text] [Related]
16. [Clinico-immunologic evaluation of the effect of decaris (levamisole) in chronic lymphoid leukemia].
Streneva TN; Shalaev VA; Krylova IV
Probl Gematol Pereliv Krovi; 1982 Sep; 27(9):20-3. PubMed ID: 6983689
[No Abstract] [Full Text] [Related]
17. Levamisole treatment of recurrent spastic bronchitis in children--the effect on selected parameters of immunologic and hemostatic systems.
Prusek W; Wieczorek E; Podwysocka M; Maćkowiak J
Arch Immunol Ther Exp (Warsz); 1985; 33(6):803-9. PubMed ID: 3914252
[TBL] [Abstract][Full Text] [Related]
18. [Increased immune reactivity in systemic lupus erythematosus. III. Different in vitro stimulation of lymphocytic populations by mitogenic serum factors (author's transl)].
Günther W; Diezel W; Meffert H; Sönnichsen N
Dermatol Monatsschr; 1978 Oct; 164(10):711-4. PubMed ID: 310779
[No Abstract] [Full Text] [Related]
19. [Clinical effect and changes in the indices of immune reactivity in patients with protracted pneumonia treated with levamisole].
Sil'vestrov VP; Konstantinova IV; Koroleva NV; Reznikov IuP; Guseva OA
Ter Arkh; 1981; 53(10):24-9. PubMed ID: 6976012
[No Abstract] [Full Text] [Related]
20. [Levamisole treatment experience with infectious allergic bronchial asthma].
Provotorov VM; Nikitin AV; Buravleva IV
Klin Med (Mosk); 1981 Apr; 59(4):13-8. PubMed ID: 6972464
[No Abstract] [Full Text] [Related]
[Next] [New Search]
